NVCR (STOCKS)
NovoCure Limited Ordinary Shares
$12.450000
+1.950000 (+18.57%)
Prev close: $10.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Frank Leonard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,405.37M
- Employees
- 1,488
- P/E (TTM)
- -7.77
- P/B (TTM)
- 3.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.33 | $-0.43 | +0.0994 | +23.15% |
|
Jun 2025 (Q2)
|
$-0.36 | $-0.39 | +0.0318 | +8.12% |
|
Mar 2025 (Q1)
|
$-0.31 | $-0.47 | +0.1636 | +34.54% |
|
Dec 2024 (Q4)
|
$-0.61 | $-0.35 | -0.2593 | -73.94% |
Financial Statements
| Revenues | $642.27M |
| Benefits Costs and Expenses | $792.77M |
| Cost Of Revenue | $158.19M |
| Costs And Expenses | $792.77M |
| Gross Profit | $484.08M |
| Operating Expenses | $660.79M |
| Depreciation and Amortization | $13.54M |
| Research and Development | $214.85M |
| Other Operating Expenses | $432.41M |
| Operating Income/Loss | -$176.71M |
| Income/Loss From Continuing Operations After Tax | -$177.65M |
| Income/Loss From Continuing Operations Before Tax | -$150.50M |
| Income Tax Expense/Benefit | $27.15M |
| Net Income/Loss | -$177.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$177.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$177.65M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.61 |
| Diluted Earnings Per Share | -$1.61 |
| Basic Average Shares | 111,414,399 |
| Diluted Average Shares | 111,414,399 |
| Assets | $1.36B |
| Current Assets | $1.20B |
| Inventory | $39.10M |
| Other Current Assets | $1.16B |
| Noncurrent Assets | $161.34M |
| Fixed Assets | $79.98M |
| Other Non-current Assets | $81.36M |
| Liabilities | $1.02B |
| Current Liabilities | $776.01M |
| Noncurrent Liabilities | $243.86M |
| Equity | $341.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $341.33M |
| Liabilities And Equity | $1.36B |
| Net Cash Flow From Operating Activities | -$34.48M |
| Net Cash Flow From Operating Activities, Continuing | -$34.48M |
| Net Cash Flow From Investing Activities | $78.74M |
| Net Cash Flow From Investing Activities, Continuing | $78.74M |
| Net Cash Flow From Financing Activities | $110.84M |
| Net Cash Flow From Financing Activities, Continuing | $110.84M |
| Exchange Gains/Losses | $342.00K |
| Net Cash Flow | $155.44M |
| Net Cash Flow, Continuing | $155.10M |
| Comprehensive Income/Loss | -$178.08M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$178.08M |
| Other Comprehensive Income/Loss | -$140.81M |